Greg D Plowman

Research

SUGEN Incorporated

Claim

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 268 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

Supplementary Information from Aurora A Kinase Inhibition is Synthetic Lethal with Loss of the RB1 Tumor Suppressor Gene

Xueqian Gong, Jian Du,Stephen H. Parsons,Farhana F. Merzoug,Yue Webster,Philip W. Iversen, Li-Chun Chio,Robert D. Van Horn, Xi Lin,Wayne Blosser,Bomie Han,Shaoling Jin, Sufang Yao,Huimin Bian, Chris Ficklin, Li Fan,Avnish Kapoor,Stephen Antonysamy, Ann M. Mc Nulty,Karen Froning,Danalyn Manglicmot,Anna Pustilnik,Kenneth Weichert,Stephen R. Wasserman,Michele Dowless,Carlos Marugán,Carmen Baquero,María José Lallena,Scott W. Eastman,Yu-Hua Hui,Matthew Z. Dieter,Thompson Doman,Shaoyou Chu,Hui-Rong Qian,Xiang S. Ye,David A. Barda,Gregory D. Plowman,Christoph Reinhard,Robert M. Campbell,James R. Henry,Sean G. Buchanan

openalex（2023）

Cited0Views0Bibtex

Figure S3 from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity

Helen Kotanides,Rose Marie Sattler,Maria B. Lebron,Carmine Carpenito,Juqun Shen,Jingxing Li,David Surguladze,Jaafar N. Haidar,Colleen Burns,Leyi Shen,Ivan Inigo,Anthony L. Pennello,Amelie Forest,Xinlei Chen,Darin Chin,Andreas Sonyi,Michael Topper,Lauren Boucher, Prachi Sharma,Yiwei Zhang,Douglas Burtrum,Ruslan D. Novosiadly,Dale L. Ludwig,Gregory D. Plowman,Michael Kalos

openalex（2023）

Cited0Views0Bibtex

Supplementary Figure S1 from ERK Inhibitor LY3214996 Targets ERK Pathway–Driven Cancers: A Therapeutic Approach Toward Precision Medicine

Shripad V. Bhagwat,William T. McMillen,Shufen Cai,Baohui Zhao,Matthew Whitesell,Weihua Shen,Lisa Kindler,Robert S. Flack,Wenjuan Wu,Bryan Anderson, Yan Zhai,Xiu-Juan Yuan,Meghann Pogue,Robert D. Van Horn,Xi Rao,Denis McCann,Andrew J. Dropsey,Jason Manro,Jennie Walgren,Eunice Yuen,Michael J. Rodriguez,Gregory D. Plowman,Ramon V. Tiu,Sajan Joseph,Sheng-Bin Peng

openalex（2023）

Cited0Views0Bibtex

Supplementary Figures S1 - S7, Tables S1 - S2 from Oncogenic BRAF Deletions That Function As Homodimers and Are Sensitive to Inhibition by RAF Dimer Inhibitor LY3009120

Shih-Hsun Chen,Youyan Zhang,Robert D. Van Horn,Tinggui Yin,Sean Buchanan,Vipin Yadav,Igor Mochalkin,Swee Seong Wong,Yong Gang Yue,Lysiane Huber,Ilaria Conti,James R. Henry,James J. Starling,Gregory D. Plowman,Sheng-Bin Peng

openalex（2023）

Cited0Views0Bibtex

Supplementary Materials and Methods from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity

openalex（2023）

Cited0Views0Bibtex

Figure S4 from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity

openalex（2023）

Cited0Views0Bibtex

Figure S7 from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity

openalex（2023）

Cited0Views0Bibtex

Supplementary Table S2 from ERK Inhibitor LY3214996 Targets ERK Pathway–Driven Cancers: A Therapeutic Approach Toward Precision Medicine

openalex（2023）

Cited0Views0Bibtex

Supplementary Table S1 from ERK Inhibitor LY3214996 Targets ERK Pathway–Driven Cancers: A Therapeutic Approach Toward Precision Medicine

openalex（2023）

Cited0Views0Bibtex

Figure S8 from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity

openalex（2023）

Cited0Views0Bibtex

Author Statistics

#Papers: 268

#Citation: 26691

H-Index: 75

G-Index: 159

Sociability: 7

Diversity: 2

Activity: 11

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn